According to Vir Biotechnology
's latest financial reports the company has a price-to-book ratio of 0.7005.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.8510 | -47.51% |
2022-12-31 | 1.62 | -57.64% |
2021-12-31 | 3.83 | -19.58% |
2020-12-31 | 4.76 | 46.28% |
2019-12-31 | 3.25 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.93 | 318.90% | ๐บ๐ธ USA |